Eledon Pharmaceuticals (ELDN) Non Operating Income (2015 - 2016)

Eledon Pharmaceuticals (ELDN) posted Non Operating Income of $54000.0 for Q1 2016, up 35.0% on a QoQ basis from $40000.0 in Q1 2015, and up 35.0% year-over-year from $40000.0 in Q2 2015.

Eledon Pharmaceuticals (ELDN) Non Operating Income (2015 - 2016) Analysis & Trends

Eledon Pharmaceuticals' Non Operating Income history runs 2 years deep, the most recent figure standing at $54000.0 for Q1 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -9.22 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 188.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 5.75 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -8.59 Mn
10 Eledon Pharmaceuticals 5.43 Mn -105.66 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2016 54,000.00
Mar 31, 2015 40,000.00